Skip to product information
1 of 1

MULTI SCIENCES

Rat EGF ELISA Kit Distributor

Rat EGF ELISA Kit Distributor

SKU:EK393

Regular price Send Inquiry
Regular price Sale price Send Inquiry
Sale Sold out
View full details

Product Details

Rat EGF ELISA Kit Distributor

Brand MultiSciences
CatNum 70-EK393
Product Name Rat EGF ELISA Kit
Customs Name Rat EGF ELISA Kit
Application ELISA
Reactivity Rat
Assay Type Sandwich ELISA
Suitable Sample Type serum, plasma, cell culture supernates
Format 96-well strip plate
Storage 4℃ (unopened) standard stored at -20℃, others stored at 4℃ (opened)
Shipping Condition 4℃
Sample Volume 20 μl
Sensitivity 0.33 pg/ml
Standard Curve Range 15.63 - 1000 pg/ml
Spike Recovery Range 94 % - 110 %
Mean Spike Recovery 1.01
CV of Intra plate 1.7 % - 5.0 %
CV of Inter plate 5.9 % - 7.5 %
Components 96-well polystyrene microplate coated with a monoclonal antibody against EGF
Rat EGF Standard, lyophilized
EGF Detect Antibody
Standard Diluent
Streptavidin-HRP
Assay Buffer (10×)
Substrate (TMB)
Stop Solution
Washing Buffer (20×)
Plate Covers
Describtion This assay employs the quantitative sandwich enzyme immunoassay technique for the quantitative detection of rat EGF. The Rat EGF ELISA is for research use only. Not for diagnostic or therapeutic procedures.
Epidermal growth factor (EGF) is a growth factor that stimulates cell growth, proliferation, and differentiation by binding to its receptor EGFR. EGF is a low-molecular-weight polypeptide first purified from the mouse submandibular gland, but since then found in many human tissues including submandibular gland, parotid gland. Salivary EGF, which seems also regulated by dietary inorganic iodine, also plays an important physiological role in the maintenance of oro-esophageal and gastric tissue integrity. The biological effects of salivary EGF include healing of oral and gastroesophageal ulcers, inhibition of gastric acid secretion, stimulation of DNA synthesis as well as mucosal protection from intraluminal injurious factors such as gastric acid, bile acids, pepsin, and trypsin and to physical, chemical and bacterial agents.Increased activity of the receptor for EGF has been observed in certain types of cancer, often correlated with mutations in the receptor and abnormal function such as constitutive receptor signalling independent of the levels of EGF or of binding of EGF.